Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

Human Gene Therapy

Volumn 11, Issue 10, 2000, Pages 1465-1475

  Heslop, Helen ^a,b   Rooney, Cliona ^a,b   Brenner, Malcolm ^a,b   Krance, Robert ^a,b   Carrum, George ^a,b   Gahn, Benedikt ^a,b   Bollard, Catherine ^a,b   Khan, Shakila ^a,b   Gee, Adrian ^a,b   Popat, Uday ^a,b   Gresik, Mary ^a,b   Przepiorka, Donna ^a,b   Kuehnle, Ingrid ^a,b   Grilley, Bambi ^a,b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEOMYCIN;

BONE MARROW TRANSPLANTATION; CANCER STAGING; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; EPSTEIN BARR VIRUS; HLA TYPING; HODGKIN DISEASE; HUMAN; MARKER GENE; RELAPSE; REVIEW; STATISTICAL ANALYSIS; TREATMENT PLANNING;

BONE MARROW TRANSPLANTATION; CELL LINE; DRUG RESISTANCE, NEOPLASM; FEASIBILITY STUDIES; FEMALE; GENE THERAPY; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; MALE; NEOMYCIN; RECURRENCE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034235967     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050057530     Document Type: Review

References (28)

1. 1. Cancer Incidence in Five Continents, Vol. VI. Eds. Parkin DM, Muir CS, et al. IARC Scientific Publication No. 120. 1992.
2. 2. Donaldson SS, Kaplan HS. In: Advances in Malignant Lymphomas. Etiology, Immunology, Pathology and Treatment. Kaplan HS and Rosenberg SA (eds). New York: Academic Press, 1982, pp. 571-590.
3. 3. Henle W, Diehl V, Kohn G, et al. Science 157:1064, 1967.
4. 4. Lenoir GM, Bornkamm GW. In: Advances in Viral Oncology, vol. 7. Klein G, ed. New York: Raven Press, 1986, p. 173.
5. 5. Cleary ML, Epstein MA, Finerty S, et al. Science 228:722, 1985.
6. 6. Cooper NR, Moore ND, Nemerov GR. Annu Rev Immunol 6:85, 1988.
7. 7. Miller G. In: Virology. Fields BN and Knipe DM (eds). New York: Raven Press, 1990, pp. 1921-1958.
8. 8. Hanto DW, Frizzera G, et al. Transplantation 39:461-472, 1985.
9. 9. List AF, Greco A, et al. Clin Oncol 5:1673-1689, 1987.
10. 10. Murray RJ, Kurilla MG, et al. Proc Natl Acad Sci USA 87:2906-2910, 1990.
11. 11. Weiss LM, Strickler JG, et al. Am J Pathol 129:86, 1987.
12. 12. Wu TC, Mann RB, et al. Int J Cancer 46:801, 1990.
13. 13. Grasser FA, Murray PG, et al. Blood 84(11):3792, 1994.
14. 14. Chang KL, Albujar PF, et al. Blood 81(2):496, 1993.
15. 15. Colby TV, Hoppe RT, et al. Cancer 49:1848, 1982.
16. 16. Chelloul N, Burke J, et al. Report on histological analysis. Histochemical Testing 767, 1972.
17. 17. Klein G. Cell 77:791, 1994.
18. 18. Khanna R, Burrows SR, et al. J Exp Med 176, 1992.
19. 19. Cohen KI. Proc Natl Acad Sci USA 86:9558, 1991.
20. 20. List AF, Greco A, et al. J. Clin Oncol 5:1673, 1987.
21. 21. Harrington DS, Weisenburger DD, et al. Cancer 59:1419, 1987.
22. 22. Rooney CM, Smith CA, et al. Lancet 344, 1995.
23. 23. Deacon EM, Pallesen G, et al. J Exp Med 177:339, 1993.
24. 24. Lee SP. Semin Virol 5:281, 1994.
25. 25. Murray RJ, Kurilla MG, et al. J Exp Med 176:157, 1992.
26. 26. Popeema S, Visser L, et al. Am J Pathol 145(1):37, 1994.
27. 27. Munro JM, Freedman AS, et al. Blood 83(3):793, 1994.
28. 28. Khanna R, Burrows SR, et al. Int J Immunol 6(4):639, 1994.